메뉴 건너뛰기




Volumn 95, Issue 7-8, 2002, Pages 661-665

Hypertension management in patients with type 2 diabetes;Prise en charge de l'hypertension artérielle chez le diabétique de type 2

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN;

EID: 0036657204     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (9)
  • 1
    • 0032703485 scopus 로고    scopus 로고
    • Épidémiologie, prise en chorge et coût du diobète de type 2 en France en 1998
    • Detournay B, Vauzelle-Kervroedan F, Charles MA et al. Épidémiologie, prise en chorge et coût du diobète de type 2 en France en 1998. Diabetes Metab 1999; 25: 356-65.
    • (1999) Diabetes Metab , vol.25 , pp. 356-365
    • Detournay, B.1    Vauzelle-Kervroedan, F.2    Charles, M.A.3
  • 2
    • 0027406191 scopus 로고
    • Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
    • Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
    • (1993) Diabetes Care , vol.16 , pp. 434-444
    • Stamler, J.1    Vaccaro, O.2    Neaton, J.D.3    Wentworth, D.4
  • 3
    • 0032701429 scopus 로고    scopus 로고
    • Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics
    • Wan Nazaimoon WM, Letchuman R, Noraini N et al. Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics. Diabetes Res Clin Pract 1999; 46: 213-21.
    • (1999) Diabetes Res Clin Pract , vol.46 , pp. 213-221
    • Wan Nazaimoon, W.M.1    Letchuman, R.2    Noraini, N.3
  • 4
    • 0033948880 scopus 로고    scopus 로고
    • Stratégie de la prise en charge du patient diabétique de type II à l'exclusion de la prise en charge des complications
    • ANAES. Stratégie de la prise en charge du patient diabétique de type II à l'exclusion de la prise en charge des complications. Diabetes Metab 2000; 26: 232-43.
    • (2000) Diabetes Metab , vol.26 , pp. 232-243
  • 5
    • 0033663743 scopus 로고    scopus 로고
    • Epidemiological analysis of patients with type 2 diabetes in France
    • Grimaldi A, Grangé V, Allanic H et al. Epidemiological analysis of patients with type 2 diabetes in France. J Diabetes Complications 2000; 14: 242-9.
    • (2000) J Diabetes Complications , vol.14 , pp. 242-249
    • Grimaldi, A.1    Grangé, V.2    Allanic, H.3
  • 6
    • 0003191031 scopus 로고
    • First International Study of Infarct Survival Collaborative Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1 Group
    • First International Study of Infarct Survival Collaborative Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1 Group. Lancet 1986; 2: 57-66.
    • (1986) Lancet , vol.2 , pp. 57-66
  • 7
    • 0033670847 scopus 로고    scopus 로고
    • Managing type 2 diabetes in France: The ECODIA survey
    • Detournay B, Cros S, Charbonnel B et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab 2000; 26: 363-9.
    • (2000) Diabetes Metab , vol.26 , pp. 363-369
    • Detournay, B.1    Cros, S.2    Charbonnel, B.3
  • 8
    • 7344263454 scopus 로고    scopus 로고
    • Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
    • UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998; 317: 720-6.
    • (1998) BMJ , vol.317 , pp. 720-726
  • 9
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.